Literature DB >> 7249509

Salicylate metabolite kinetics after several salicylates.

F Bochner, G G Graham, B E Cham, D M Imhoff, T M Haavisto.   

Abstract

Single oral doses of aspirin (ASA, 1,500 mg), sodium salicylate (NaSA, 1,500 mg, 1,200 mg), and salicyluric acid (SUA, 500 mg) were given to five subjects. Serial plasma and urine samples were collected for 24 hr (plasma) and up to 48 hr (urine); salicylic acid (SA), SUA, and gentisic acid (GA) were measured by high-pressure liquid chromatography. The plasma concentration/time profiles for SUA after ASA and NaSA were fitted to the empirical equation CpSUA = A-Bt-Ce-alpha t -- (A-C)e-beta t. Michaelis constants (Vm and Km) for the conversion of SA to SUA were calculated from the equation (formula see text), where Cl is the renal clearance of SUA, ke is the rate constant of elimination of SUA, CpSA is the plasma concentration of salicylic acid. The term Cl (formula see text) is the estimated rate of formation of SUA from SA at any time (t). The calculated values (mean +/- SD) of Vm, Km, and Kmf (Km in terms of unbound SA) were 43.4 +/- 10.1 mg SA/hr, 14.3 +/- 3.4 mg SA/l plasma, and 0.75 +/- 0.15 mg unbound SA/l plasma. The Vm values were in accord with those reported, but the value for Km was considerably lower. Renal clearances of SUA and GA were 340 +/- 51 and 65 +/- 10 ml/min.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249509     DOI: 10.1038/clpt.1981.158

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform.

Authors:  Wojciech G Lesniak; Nikita Oskolkov; Xiaolei Song; Bachchu Lal; Xing Yang; Martin Pomper; John Laterra; Sridhar Nimmagadda; Michael T McMahon
Journal:  Nano Lett       Date:  2016-03-01       Impact factor: 11.189

2.  Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease.

Authors:  M S Roberts; R H Rumble; S Wanwimolruk; D Thomas; P M Brooks
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  [Reversible inhibition of thrombocyte stimulation by acetylsalicylic acid and its role in antithrombotic therapy].

Authors:  R Simrock; H Spahn; H K Breddin; E Mutschler
Journal:  Klin Wochenschr       Date:  1983-03-15

Review 4.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.

Authors:  B P Haynes; M Jarman; M Dowsett; A Mehta; P E Lønning; L J Griggs; A Jones; T Powles; R Stein; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

Review 7.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

8.  The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites.

Authors:  P C Ho; E J Triggs; D W Bourne; V J Heazlewood
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

9.  Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.

Authors:  F Bochner; G G Graham; A Polverino; D M Imhoff; R A Tregenza; P E Rolan; L G Cleland
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Spatiotemporal integration of molecular and anatomical data in virtual reality using semantic mapping.

Authors:  Jung Soh; Andrei L Turinsky; Quang M Trinh; Jasmine Chang; Ajay Sabhaney; Xiaoli Dong; Paul Mk Gordon; Ryan Pw Janzen; David Hau; Jianguo Xia; David S Wishart; Christoph W Sensen
Journal:  Int J Nanomedicine       Date:  2009-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.